Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Cell Reports|August 31, 2022
Circulating tumor cell-blood cell crosstalk: Biology and clinical relevanceThais Pereira-Veiga, Svenja Schneegans, Klaus Pantel, et al.
Neuromolecular Medicine|February 7, 2013
Increased 5-methylcytosine and decreased 5-hydroxymethylcytosine levels are associated with reduced striatal A2AR levels in Huntington's diseaseIzaskun Villar-Menéndez, Marta Blanch, Shiraz Tyebji, et al.
Neurobiology of Disease|June 4, 2014
Increased striatal adenosine A2A receptor levels is an early event in Parkinson's disease-related pathology and it is potentially regulated by miR-34bIzaskun Villar-Menéndez, Sílvia Porta, Sandra P Buira, et al.
Journal of Psychiatric Research|January 18, 2014
Reduced striatal adenosine A2A receptor levels define a molecular subgroup in schizophreniaIzaskun Villar-Menéndez, Sara Díaz-Sánchez, Marta Blanch, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 9, 2024
Isolation of Single Circulating Tumor Cells Using VyCAP Puncher SystemThais Pereira-Veiga, Bianca Behrens, Joska J Broekmaat, et al.
Scientific Reports|May 31, 2019
Fast and efficient microfluidic cell filter for isolation of circulating tumor cells from unprocessed whole blood of colorectal cancer patientsSilvina Ribeiro-Samy, Marta I Oliveira, Thais Pereira-Veiga, et al.
Biomedicines|November 26, 2022
Circulating Cancer Associated Macrophage-like Cells as a Potential New Prognostic Marker in Pancreatic Ductal AdenocarcinomaChristine Nitschke, Benedikt Markmann, Leonie Konczalla, et al.
Cancers|December 11, 2019
CTCs Expression Profiling for Advanced Breast Cancer MonitoringThais Pereira-Veiga, Mónica Martínez-Fernández, Carmen Abuin, et al.
Cancers|May 6, 2020
Analysis of a Real-World Cohort of Metastatic Breast Cancer Patients Shows Circulating Tumor Cell Clusters (CTC-clusters) as Predictors of Patient OutcomesClotilde Costa, Laura Muinelo-Romay, Victor Cebey-López, et al.
Cancer Cell International|March 17, 2023
The role of the desmosomal protein desmocollin 2 in tumour progression in triple negative breast cancer patientsFrancesca Reimer, Sarah Bryan, Karen Legler, et al.
Pageof 2